Back to Search Start Over

Medical Products for Cardiovascular Disease Management in Nepal: a needs assessment study.

Authors :
Sapkota S
Shrestha S
Bista D
Shrestha A
Maharjan R
Bajracharya S
Jha N
Koju RP
Shrestha R
Source :
Kathmandu University medical journal (KUMJ) [Kathmandu Univ Med J (KUMJ)] 2021 CARDIOVASCULAR DISEASES (CVDs) SPECIAL ISSUE; Vol. 19 (75), pp. 18-29.
Publication Year :
2021

Abstract

Background Medical Products and Technologies is a key component of the health system. Quality medicines and efficient management of the medical products can secure effective cardiovascular diseases management. Objective To collate information and identify strengths, weaknesses, opportunities and threats (SWOT) associated with medical products and technology component for cardiovascular disease management in Nepal. Method This study is a part of a larger rapid assessment of Nepal's health system for cardiovascular disease management and based on The Health System Assessment Approach: A How-To Manual (USAID). The authors conducted a desk review of documents related to the WHO "medical product and technology" building block component and key informant interviews using a pre-tested interview protocol. The first eight interviews were transcribed verbatim and analysed inductively to generate a codebook; and the remaining, transcribed and deductively coded based on the codebook. Findings were categorised into relevant topical area and SWOT components. Result Nepal has laws and provisions for medicine regulation, pharmacovigilance, post marketing surveillance, registration and licensing provisions for pharmacy industries/ outlets, essential medicine lists and national formulary. These provisions also apply to medicines used for cardiovascular diseases. The challenge however, is the lack of effective implementation and monitoring, due to shortages of technical workforce and state of art information and technologies. Information on pharmaceutical expenditures for cardiovascular disease management is scarce; there are no standard national level guidelines that are consistently used to manage cardiovascular diseases in health facilities. Conclusion There are limited provisions and information on medical products for cardiovascular disease management in Nepal, and a need to strengthen existing provisions for medicine regulations and surveillance.

Details

Language :
English
ISSN :
1812-2078
Volume :
19
Issue :
75
Database :
MEDLINE
Journal :
Kathmandu University medical journal (KUMJ)
Publication Type :
Academic Journal
Accession number :
35526133